意大利多中心暴发与污染米力农相关的维斯瓦纳蒂念珠菌血流感染
立即措施包括撤回涉事产品、通知国家当局并对暴露患者进行主动微生物学监测。
要点
- 罕见非白色念珠菌血流感染暴发需警惕药物源性污染。
- 米力农污染是本次多中心暴发的共同暴露来源。
- 撤回涉事批次并主动监测暴露患者是关键控制措施。
核心结论
- 本次暴发由污染米力农导致,强调临床医生主导的暴发识别、假设驱动流行病学和药物警戒在发现罕见药物相关真菌感染中的重要性。
主要发现
- 共识别40例维斯瓦纳蒂念珠菌血症,均为血流感染,多数与一个主要米力农批次相关,但其他批次亦被牵涉。
- 初始本地调查未发现环境或患者间传播,米力农是受影响患者的唯一共同暴露。
- 对涉事产品培养产出维斯瓦纳蒂念珠菌,确认污染。
关键数值与推荐
- 多数病例与一个主要米力农批次相关,其他批次亦被牵涉。
临床怎么用
- 临床医生应关注罕见真菌血流感染的聚集性信号,并开展假设驱动的暴露调查。
- 怀疑药物源性感染时,应撤回涉事产品、通知国家当局并对暴露患者进行主动微生物学监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2025, a multicentre outbreak of bloodstream infections caused by Candida viswanathii, a rare non-albicans Candida species, was identified in Italy. The source was recognised after four C. viswanathii bloodstream infections were identified within a short period at a single centre. Initial local investigations did not identify environmental or patient-to-patient transmission. Given the strong geographical association of C. viswanathii with the Indian subcontinent, a hypothesis-driven investigation focusing on medicinal products of Indian origin was undertaken. Milrinone was the only common exposure among affected patients, and culture of the implicated product yielded C. viswanathii, confirming contamination. In total, 40 cases of C. viswanathii candidaemia were identified across four centres between April and October 2025; all were bloodstream infections. Most were associated with one predominant milrinone lot, although additional lots were implicated. Immediate control measures included withdrawal of the implicated product, notification of national authorities and active microbiological surveillance of exposed patients. This outbreak highlights the importance of clinician-led outbreak detection, hypothesis-driven epidemiology and pharmacovigilance in identifying rare, medicine-associated fungal infections.
引用
- Mesini A, Spiga G, Ciofi Degli Atti M, et al. Multicentre outbreak of Candida viswanathii bloodstream infections linked to contaminated milrinone, Italy, April to October 2025. Euro Surveill. 2026. PMID: 42725369. doi:10.2807/1560-7917.ES.2026.31.36.2600311
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。